deep-medical ltd Company Information
Company Number
13242918
Next Accounts
Dec 2025
Industry
Computer consultancy activities
Business and domestic software development
Shareholders
benyamin deldar
david mark james hanbury
View AllGroup Structure
View All
Contact
Registered Address
221 pentonville road, london, N1 9UZ
Website
-deep-medical ltd Estimated Valuation
Pomanda estimates the enterprise value of DEEP-MEDICAL LTD at £1.4m based on a Turnover of £2.1m and 0.64x industry multiple (adjusted for size and gross margin).
deep-medical ltd Estimated Valuation
Pomanda estimates the enterprise value of DEEP-MEDICAL LTD at £0 based on an EBITDA of £-596.4k and a 4.12x industry multiple (adjusted for size and gross margin).
deep-medical ltd Estimated Valuation
Pomanda estimates the enterprise value of DEEP-MEDICAL LTD at £2m based on Net Assets of £856.1k and 2.33x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Deep-medical Ltd Overview
Deep-medical Ltd is a live company located in london, N1 9UZ with a Companies House number of 13242918. It operates in the information technology consultancy activities sector, SIC Code 62020. Founded in March 2021, it's largest shareholder is benyamin deldar with a 42.6% stake. Deep-medical Ltd is a startup, small sized company, Pomanda has estimated its turnover at £2.1m with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
Deep-medical Ltd Health Check
Pomanda's financial health check has awarded Deep-Medical Ltd a 3 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 5 areas for improvement. Company Health Check FAQs
2 Strong
2 Regular
5 Weak
Size
annual sales of £2.1m, make it in line with the average company (£2.3m)
- Deep-medical Ltd
£2.3m - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Deep-medical Ltd
- - Industry AVG
Production
with a gross margin of 32.4%, this company has a higher cost of product (58.2%)
- Deep-medical Ltd
58.2% - Industry AVG
Profitability
an operating margin of -28.3% make it less profitable than the average company (5.1%)
- Deep-medical Ltd
5.1% - Industry AVG
Employees
with 7 employees, this is below the industry average (20)
7 - Deep-medical Ltd
20 - Industry AVG
Pay Structure
on an average salary of £63k, the company has an equivalent pay structure (£63k)
- Deep-medical Ltd
£63k - Industry AVG
Efficiency
resulting in sales per employee of £301.3k, this is more efficient (£124.3k)
- Deep-medical Ltd
£124.3k - Industry AVG
Debtor Days
it gets paid by customers after 194 days, this is later than average (60 days)
- Deep-medical Ltd
60 days - Industry AVG
Creditor Days
its suppliers are paid after 28 days, this is quicker than average (33 days)
- Deep-medical Ltd
33 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Deep-medical Ltd
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Deep-medical Ltd
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 24.4%, this is a lower level of debt than the average (56.7%)
24.4% - Deep-medical Ltd
56.7% - Industry AVG
DEEP-MEDICAL LTD financials
Deep-Medical Ltd's latest turnover from March 2024 is estimated at £2.1 million and the company has net assets of £856.1 thousand. According to their latest financial statements, Deep-Medical Ltd has 7 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Mar 2024 | Mar 2023 | Mar 2022 | |
---|---|---|---|
Turnover | |||
Other Income Or Grants | |||
Cost Of Sales | |||
Gross Profit | |||
Admin Expenses | |||
Operating Profit | |||
Interest Payable | |||
Interest Receivable | |||
Pre-Tax Profit | |||
Tax | |||
Profit After Tax | |||
Dividends Paid | |||
Retained Profit | |||
Employee Costs | |||
Number Of Employees | 7 | 5 | |
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Mar 2024 | Mar 2023 | Mar 2022 | |
---|---|---|---|
Tangible Assets | 4,164 | 6,799 | 0 |
Intangible Assets | 0 | 0 | 0 |
Investments & Other | 0 | 0 | 0 |
Debtors (Due After 1 year) | 0 | 0 | 0 |
Total Fixed Assets | 4,164 | 6,799 | 0 |
Stock & work in progress | 0 | 0 | 0 |
Trade Debtors | 1,124,097 | 1,619,854 | 4,987 |
Group Debtors | 0 | 0 | 0 |
Misc Debtors | 3,776 | 0 | 0 |
Cash | 0 | 0 | 0 |
misc current assets | 0 | 0 | 0 |
total current assets | 1,127,873 | 1,619,854 | 4,987 |
total assets | 1,132,037 | 1,626,653 | 4,987 |
Bank overdraft | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 |
Trade Creditors | 110,543 | 174,213 | 21,278 |
Group/Directors Accounts | 0 | 0 | 0 |
other short term finances | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 |
other current liabilities | 0 | 0 | 0 |
total current liabilities | 110,543 | 174,213 | 21,278 |
loans | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 |
Accruals and Deferred Income | 165,422 | 0 | 0 |
other liabilities | 0 | 0 | 0 |
provisions | 0 | 0 | 0 |
total long term liabilities | 165,422 | 0 | 0 |
total liabilities | 275,965 | 174,213 | 21,278 |
net assets | 856,072 | 1,452,440 | -16,291 |
total shareholders funds | 856,072 | 1,452,440 | -16,291 |
Mar 2024 | Mar 2023 | Mar 2022 | |
---|---|---|---|
Operating Activities | |||
Operating Profit | |||
Depreciation | |||
Amortisation | |||
Tax | |||
Stock | 0 | 0 | 0 |
Debtors | -491,981 | 1,614,867 | 4,987 |
Creditors | -63,670 | 152,935 | 21,278 |
Accruals and Deferred Income | 165,422 | 0 | 0 |
Deferred Taxes & Provisions | 0 | 0 | 0 |
Cash flow from operations | |||
Investing Activities | |||
capital expenditure | |||
Change in Investments | 0 | 0 | 0 |
cash flow from investments | |||
Financing Activities | |||
Bank loans | 0 | 0 | 0 |
Group/Directors Accounts | 0 | 0 | 0 |
Other Short Term Loans | 0 | 0 | 0 |
Long term loans | 0 | 0 | 0 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 |
other long term liabilities | 0 | 0 | 0 |
share issue | |||
interest | |||
cash flow from financing | |||
cash and cash equivalents | |||
cash | 0 | 0 | 0 |
overdraft | 0 | 0 | 0 |
change in cash | 0 | 0 | 0 |
deep-medical ltd Credit Report and Business Information
Deep-medical Ltd Competitor Analysis
Perform a competitor analysis for deep-medical ltd by selecting its closest rivals, whether from the INFORMATION AND COMMUNICATION sector, other small companies, companies in N 1 area or any other competitors across 12 key performance metrics.
deep-medical ltd Ownership
DEEP-MEDICAL LTD group structure
Deep-Medical Ltd has no subsidiary companies.
Ultimate parent company
DEEP-MEDICAL LTD
13242918
deep-medical ltd directors
Deep-Medical Ltd currently has 3 directors. The longest serving directors include Dr Benyamin Deldar (Mar 2021) and Mr David Hanbury (Mar 2021).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Dr Benyamin Deldar | England | 32 years | Mar 2021 | - | Director |
Mr David Hanbury | England | 38 years | Mar 2021 | - | Director |
Mr Steven Hess | England | 55 years | Feb 2024 | - | Director |
P&L
March 2024turnover
2.1m
-23%
operating profit
-596.4k
0%
gross margin
32.4%
-3.34%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
856.1k
-0.41%
total assets
1.1m
-0.3%
cash
0
0%
net assets
Total assets minus all liabilities
Similar Companies
deep-medical ltd company details
company number
13242918
Type
Private limited with Share Capital
industry
62020 - Computer consultancy activities
62012 - Business and domestic software development
incorporation date
March 2021
age
4
incorporated
UK
ultimate parent company
accounts
Micro-Entity Accounts
last accounts submitted
March 2024
previous names
N/A
accountant
-
auditor
-
address
221 pentonville road, london, N1 9UZ
Bank
-
Legal Advisor
-
deep-medical ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to deep-medical ltd.
deep-medical ltd Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for DEEP-MEDICAL LTD. This can take several minutes, an email will notify you when this has completed.
deep-medical ltd Companies House Filings - See Documents
date | description | view/download |
---|